GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion. The shares represented around 4.2% of the issued share capital of Haleon. Following the ...

British drugmaker GSK will spin off its consumer health business Haleon worth up to an estimated 48 billion pounds ($57 billion) on Monday in the biggest listing in Europe in over a decade. Haleon is ...

The share sale and buyback are expected to reduce Pfizer's interest in Haleon from 32% to approximately 24%. In its fourth-quarter release, Haleon added that it expects to allocate £500 million to buy ...

GlaxoSmithKline has introduced a new toothpaste delivery system that disperses active ingredients quickly, penetrating hard-to-reach areas of the mouth, according to the company. Iso-active, which is ...

Haleon has announced that it is launching as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver ...